Literature DB >> 11248790

Candidate genes and confirmed genetic polymorphisms associated with cardiovascular diseases: a tabular assessment.

Z Tang1, R P Tracy.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11248790     DOI： 10.1023/a:1008956327032

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN： 0929-5305            Impact factor:   2.300


× No keyword cloud information.
  313 in total

1.  A novel DNA polymorphism (4886C>T) in the human LCAT gene.

Authors:  D Recalde; A Cenarro; F Civeira; A L Garcia-Otin; M Pocovi
Journal:  Hum Mutat       Date:  2000-03       Impact factor: 4.878

2.  The 4G/5G polymorphism of PAI-1 promoter gene and the risk of myocardial infarction: a meta-analysis.

Authors:  L Iacoviello; F Burzotta; A Di Castelnuovo; F Zito; R Marchioli; M B Donati
Journal:  Thromb Haemost       Date:  1998-12       Impact factor: 5.249

3.  Molecular genetic study of Finns with hypoalphalipoproteinemia and hyperalphalipoproteinemia: a novel Gly230 Arg mutation (LCAT[Fin]) of lecithin:cholesterol acyltransferase (LCAT) accounts for 5% of cases with very low serum HDL cholesterol levels.

Authors:  H E Miettinen; H Gylling; J Tenhunen; J Virtamo; M Jauhiainen; J K Huttunen; I Kantola; T A Miettinen; K Kontula
Journal:  Arterioscler Thromb Vasc Biol       Date:  1998-04       Impact factor: 8.311

4.  A gain-of-function polymorphism in a G-protein coupling domain of the human beta1-adrenergic receptor.

Authors:  D A Mason; J D Moore; S A Green; S B Liggett
Journal:  J Biol Chem       Date:  1999-04-30       Impact factor: 5.157

5.  Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa.

Authors:  C J Edwards-Smith; J R Jonsson; D M Purdie; A Bansal; C Shorthouse; E E Powell
Journal:  Hepatology       Date:  1999-08       Impact factor: 17.425

6.  Common genetic variation in the promoter of the human apo CIII gene abolishes regulation by insulin and may contribute to hypertriglyceridemia.

Authors:  W W Li; M M Dammerman; J D Smith; S Metzger; J L Breslow; T Leff
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

7.  M235T angiotensinogen gene polymorphism and cardiovascular renal risk.

Authors:  J A Staessen; T Kuznetsova; J G Wang; D Emelianov; R Vlietinck; R Fagard
Journal:  J Hypertens       Date:  1999-01       Impact factor: 4.844

8.  A mutation in the promoter of the lipoprotein lipase (LPL) gene in a patient with familial combined hyperlipidemia and low LPL activity.

Authors:  W S Yang; D N Nevin; R Peng; J D Brunzell; S S Deeb
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

Review 9.  T-lymphocytes and monocytes in atherogenesis.

Authors:  G Schmitz; A S Herr; G Rothe
Journal:  Herz       Date:  1998-05       Impact factor: 1.443

10.  Detection of a new apolipoprotein-E mutation in type III hyperlipidemia using deoxyribonucleic acid restriction isotyping.

Authors:  C C Walden; M W Huff; L A Leiter; P W Connelly; R A Hegele
Journal:  J Clin Endocrinol Metab       Date:  1994-03       Impact factor: 5.958
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.